Critical Care Medicine,
#OpenAccess #COVID19 Youssef et al: #COVID-19 resp failure 💉Vasoactive Intestinal Peptide Aviptadil 📊60d RCT 2:1 Why VIP?
The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial*
Overview of attention for article published in Critical Care Medicine, August 2022
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (97th percentile)
Mentioned by
- blogs
- 1 blog
- 63 X users
- patent
- 1 patent
- 1 Facebook page
- 3 Redditors
- video
- 1 YouTube creator
- bluesky
- 2 Bluesky users
- podcasts
- 1 podcast
Readers on
- mendeley
- 42 Mendeley